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Summary 
The glycosylphosphatidylinositol (GPI)-anchored membrane protein urokinase plasminogen 
activator-receptor  (uPA-R; CD87) is one of the key molecules involved in migration of leukocytes 
and tumor cells, uPA bound to uPA-R provides the cell proteolytic potential used for degradation 
of extracellular  matrix, uPA-R is also involved in induction of ceU adhesion and chemotaxis. 
Here,  we provide a  molecular explanation for  these uPA-R-related cdlular events.  By size 
ffactionation of monocyte lysate and af~nity isolation on its natural ligand uPA, we demonstrate 
uPA-R as  a  component of a receptor complex of relatively  large  size. Reprecipitation and 
immunoblotting techniques allowed us to detect the protein tyrosine kinases  (PTKs)  p60fY  ", 
p53/56  lyn, p58/64  hck, and  p59f~  as  components of this  "uPA-R  complex".  Activation  of 
monocytes even with enzymatically inactivated uPA resulted in induction of tyrosine phosphor- 
ylation, suggesting modulation of uPA-R-associated PTKs upon ligand binding. In spite of their 
presence in large complexes, we did not find the GPI-linked proteins CD14, CD58, and CD59 
in the uPA-R complex, which indicates  the presence of different receptor domains containing 
GPI-linked proteins in monocytes. However,  we identified the leukocyte integrins LFA-1 and 
CR3 as components of the uPA-R complex as indicated by coisolation of these molecules, as 
well as by cocapping and comodulation of uPA-R and leukocyte integrins on the monocyte surface. 
The assemblage of uPA-R, PTKs and membrane spanning 32-integrins in one receptor complex 
indicates functional cooperation. In regard to the involvement of these molecules in pericellular 
proteolysis, signal transduction, as weU as adhesion and chemotactic movement, we suggest uPA-R 
complex as a potential cellular device for call migration. 
C 
ell activation, adhesion, and extracellular proteolysis are 
causally connected in leukocyte migration, a process in- 
dispensable for immunity and inflammation. The complexity 
of this process requires  concerted action and interaction of 
molecules underlying the mechanisms involved. Indeed, mol- 
ecules mediating adhesion, cell surface proteolysis as well as 
signal transduction have been colocalized  in regions of cell 
contact (1). One of these critical molecules seems to be uro- 
kinase  plasminogen activator-receptor (uPA-R)  z (2,  3) re- 
cently assigned  as CD87  antigen (4).  uPA-R is a highly 
glycosylated  50-65-kD protein linked to the plasma mem- 
brane by glycosylphosphatidylinositol (GPI) (5). It is expressed 
on mononuclear phagocytes (6), neutrophils (7),  activated 
T cells (8), endothelial cells (9), and several types of tumor 
cells (10). uPA-R focuses and controls the fibrinolytic system 
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tive form upon binding to uPA-K, and thus gains the ability 
to enzymatically digest plasminogen to the serine protease 
plasmin. This delivers to cells a spatially and temporally regu- 
lated proteolytic potential necessary for remodeling of  pericel- 
lular space during migration as well as for generation of ac- 
tive substances employed in this process. Internalization, ligand 
clearing,  and reexpression  of uPA-R are crucial devices con- 
troling uPA activity, and therefore the plasminogen system 
(3,  11). Therefore, uPA-R can be considered as one of the 
possible targets in treatment of inflammatory disorders  and 
metastasis  (10). 
In addition to its function in the fibrinolytic system, re- 
cent reports attribute a further active role to uPA-R in cell 
migration. It has been shown that incubation of myeloid cells 
with uPA results in adhesion induction (12, 13) and chemo- 
tactic movement (14, 15). Thus, there is evidence that inter- 
action of uPA-R with its ligand participates in the activation 
of migrating cells, which is required for complete migration 
and development of the inflammatory response.  These ob- 
servations  classify uPA-R, as a potential signal-transducing 
molecule in cells. Indeed, changes in tyrosine phosphoryla- 
tion (16) and diacylglycerol formation (17) have  been observed 
as a result ofuPA-R engagement. However, the mechanisms 
responsible for the signaling capacity of uPA-K and its effects 
on adhesion and chemotaxis regulation, have so far remained 
unclear. 
Here, we report that uPA-R, is a component of a multi- 
meric receptor complex in human monocytes. Using its nat- 
ural ligand, uPA, we coisolated four members of the Src-protein 
tyrosine kinase (PTK) family with uPA-R, and provide evi- 
dence for their involvement in signal transduction by induc- 
tion of tyrosine phosphorylation through uPA. Furthermore, 
we demonstrate the presence of~2-integrins, molecules func- 
tionally important for cell adhesion and migration, in this 
receptor complex. 
Materials and Methods 
Cells.  Peripheral blood monocytes were isolated from the pe- 
ripheral blood of healthy individuals by density gradient centrifu- 
gation over Ficoll-Hypaque  (Pharmacia, Uppsala, Sweden), followed 
by removal of the E-rosette-forming fraction (18). These prepara- 
tions contained at least 75% CD14-positive cells and were free of 
other blood cells expressing  uPA-R, as analyzed  by flow cytometry. 
Antibodies.  Mouse mAbs E4  (IgG2b), F10 (IgG1), and H2 
(IgG1) against uPA-R were obtained as a result of immunization 
with recombinant soluble human uPA-R (19). Using an uPA-R 
ELISA (19), mAbs E4 and F10 were found not to compete for 
binding ofuPA to uPA-R, whereas anti-uPA-R mAbs VIM5 (IgG1; 
reference 7) and no. 3936 (IgG2a; purchased from American Diag- 
nostica, Greenwich, CT) inhibited uPA binding, mAbs MEM-57 
(IgG2a) to CD3; MEM-83 (IgG1) to CD11a; MEM-95 (IgG1) to 
CDlla; 5E6 (IgG1) to CDlla; MEM-170 (IgG1) to CDllb; VIM12 
(IgG1) to CDllb; MEM-18 (IgG1) to CD14; MEM-48 (IgG1) to 
CD18; 7E4 (IgG2a) to CD31; MEM-59 (IgG1) to CD43; MEM-56 
(IgG2b) to CD45RA;  MEM-43 (lgG2a) to CD59; 132 (IgG2b) 
to M6; VIAP (IgG1) to alkaline  phosphatase; and B2M-01 (IgG2a) 
and B2M-02 (IgG1) both against human B2-microglobulin, were 
prepared and characterized  in our laboratories. Specificities  of these 
mAbs were confirmed  by the 3rd, 4th, and 5th International Work- 
shop and Conference On Human Leucocyte Differentiation An- 
tigens, with the exception of mAbs B2M-01 and B2M-02 (20), 
MEM-48 (21), 7E4 (22), 5E6 (23), VIAP, 132, and MEM-170. A 
clone TS2/9 producing mAb to CD58 (IgG1) was obtained from 
the American Type Culture Collection (Rockville, MD).  mAb 
BU-15 (IgG1) to CD11c was purchased from The Binding Site (Bir- 
mingham, UK) and mAb IV.3 (IgG1) to CD32 from Medarex  Inc. 
(West Lebanon, NH). mAbs PEN-2 (IgG2a) to CD11b and Ki-M1 
(IgG1) to CD11c were samples from the 3rd and 5th International 
Workshops On Human Leucocyte  Differentiation Antigens. mAb 
KIM127 to CD18 (24) was a gift from Dr. M. K. Robinson (Stan- 
ford University, Palo Alto, CA). The mouse mAb and the rabbit 
polyclonal  Ab to caveolin  were purchased from Transduction Lab- 
oratories (lexington, KY). Rabbit polyclonal Abs against Lyn, 
Fgr, and Hck were purchased from Santa Cruz  Biotechnology 
(Santa Cruz,  CA).  Rabbit  antiserum  against Fyn  was  kindly 
provided by Dr. A. Veillette  (McGill University,  Montreal, Canada). 
Rabbit antiserum against the p85 subunit of phosphatidylinositol 
3-kinase and anti-phosphotyrosine mAb 4G10 were from UBI 
(Lake Placid, NY). 
Preparation ofuPA-Sepharose.  Inactivated  uPA (Serva, Heidel- 
berg, Germany),  or BSA were coupled to CNBr-activated  Sepharose 
4B (Pharmacia) as recommended by the manufacturer, except that 
the coupling was performed in a buffer containing 50 mM H3BO3 
and 0.5 M NaC1 (pH 8.0), at room temperature for 90 min. 
Immunoprecipitation and In Vitro Kinase Assay.  Freshly  isolated 
monocytes  were pretreated with 5 mM diisopropyl  fluorophosphate 
(DFP) for 6 min, and lysed in ice-cold lysis buffer containing 20 
mM T_ris (pH 8.2), 140 mM NaC1, 2 mM EDTA, 1% Brij-58 (Pierce, 
Rockford, IL), 5 mM iodoacetamide,  aprotinin and leupeptin (both 
10 #g/ml), 1 mM PMSF, 0.1 mM quercetin, 0.1 mM N-tosyl-L- 
phenylalanine chlormethyl ketone, 0.1  mM  N~-p-tosyl-r-lysine 
chlormethyl ketone, 0.1 mM N-CBZ-t-phenylalanine  chlormethyl 
ketone (all from Sigma Chemical Co., St. Louis, MO) for 30 min. 
The lysates were subjected to immunoprecipitation by the solid 
phase immunoisolation technique on 96-welt plastic plates, as de- 
scribed (25). For isolation of uPA-R with its natural ligand, uPA 
(40/~g/ml) was directly coated on plastic plates instead of mAbs. 
Alternatively, uPA-Sepharose (see above) was used as an adsorp- 
tion matrix. After washing isolated material with lysis buffer, an 
in vitro kinase assay  was performed by adding 25 mM Hepes (pH 
7.2),  5 mM MnC12, 20 mM MgC12, and 1 #Ci of y-[32p]ATP 
(3,000 Ci/mmol) (NEN, Boston, MA). 32p-labeled proteins were 
analyzed by SDS-PAGE and autoradiography. 
For analysis by reprecipitation, uPA-R was affinity-isolated  on 
uPA-Sepharose by incubation with void volume fractions of cell 
lysate (see below) for 4 h at 4~  After in vitro kinase assay, phos- 
phorylated proteins were eluted from uPA-Sepharose  by lysis  buffer 
containing 1% SDS (instead of Brij-58) for 10 min at room tem- 
perature, and then diluted 10x  with lysis buffer containing 1% 
NP-40. This material was subjected to reprecipitation with indi- 
cated Abs for 3 h on ice. Immune complexes were collected with 
a fixed cell suspension of Staphylococcus aureus-Protein  A (Sigma 
Chem. Co.), washed and analyzed  by SDS-PAGE and autoradiog- 
raphy. Alternatively,  the uPA-Sepharose  isolated  material was eluted 
by the SDS-PAGE sample  buffer and analyzed  by immunoblotting. 
Immunoprecipitation of integrins was performed with mAbs 
covalently attached on Eupergit  CIZ particles (R6hm  GmbH, 
Weiterstadt, Germany) (26). 
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for I h in 5% nonfat milk, and immunostained by sequential incu- 
bation with specific  mouse or rabbit Abs, followed by appropriate 
second  Abs conjugated with peroxidase  (Bio-Rad  Labs, Richmond, 
CA). The enhanced chemiluminescence  detection system (Amer- 
sham, Aylesbury,  UK) was used for visualization  of  hbeled proteins. 
Gel Chromatography.  The minicolumns (0.8 cm x  5 cm, total 
volume 3 ml) of Sepharose 4B (Pharmacia) were used as described 
(27). Briefly, after equilibration of the column with lysis buffer, 
0.3 ml of cell lysate was applied on the top. Subsequently, 0.3-ml 
fractions of the duate were collected, which were used either for 
immunoprecipitation  or  immunoblotting.  Calibration  of this 
column r~yaled its void  volume in fractions  4, 5 (the elution volume 
of erythrocytes), and the elution volumes of IgM, and IgG were 
in the fractions 7 and 9, respectively. 
TFosine Phosphorylation Analysis.  Freshly isolated monocytes 
(2 x  10  ~ cdls/ml in RPMI 1640 medium with 10% FCS) were 
incubated  with 50 nM uPA (kindly  provided  by Technoclon,  Vienna, 
Austria) or 50 nM DFP-inactivated  uPA for 5 and 15 min at 370C. 
Afterwards, the cells  were briefly pelleted in a microfuge and solu- 
bilized as described above, except that 1% NP-40 and 0.1% deoxy- 
cholic acid were contained as detergents in the lysis buffer. Cell 
lysates were analyzed by SDS-PAGE and immunoblotting  using 
mAb 4G10 (UBI) for detection of tyrosine-phosphorylated pro- 
teins. DFP-inactivated  uPA manifested  undetectable enzymatic ac- 
tivity, as assayed  by a phsminogen-dependent system (28). The LPS 
concentrations of the reagents employed  in the treatment of  mono- 
cytes were measured as described (29) by using the turbidimetric 
LAbendotoxin assay  from Pyrotell (Woods Hole, MA), and found 
to be <10 pg/ml in each sample. This is >1 log below the reported 
stimulatory level of the LPS-induced  protein tyrosine phosphory- 
lation in macrophages (30). 
Cocapping.  Freshly isolated monocytes were treated for 3 min 
with acid glycine (50 mM glycine, 100 mM NaCI, pH 3.0) to re- 
move  cell-bound  uPA and incubated  for 30 min at 4~  with 4 mg/ml 
of human Ig to block nonspecific  FcR-mediated  binding of mAbs. 
Cells (5  x  10  s in 50/~1 RPMI 1640 medium containing 10% FCS 
and 20 mM Hepes) were incubated for 30 rain at 4~  with 1/~g 
mAb, washed, and the FITC-conjugated sheep F(ab')z anti-mouse 
IgG+IgM Abs (Grub, Scandic, Vienna, Austria) were added. To 
induce capping, the samples were shifted to 37~  for 5 min. After 
washing with PBS containing 1% BSA and 0.1% sodium azide, 
uPA-R was stained by sequential  incubation with biotinylated uPA 
(biotin-X-NHS;  Calbiochem-Novabiochem, La Jolla,  CA)  and 
tetramethylrhodamine isothiocyanate  (TRITC)-conjugated  strep- 
tavidin (Accurate Chemical & Scientific Corp., Westbury, NY). 
For coclustering analysis  of PTKs, capped cells were permeabilized 
with 0.3% saponin, immunolabeled with the respective  rabbit an- 
tisera to the Src-PTKs, fixed  with 1% paraformaldehyde,  and stained 
with TRITC-conjugated goat anti-rabbit IgG Abs (Accurate  Chem- 
ical & Scientific  Corp.). The ceils were examined by fluorescence 
microscopy. 
Antigen Modulation.  Untreated  or formaldehyde fixed (1%) 
mononuclear cells were incubated with either 10 #g/m1 of CD18 
mAb KIM127 or isotype control mAb VIAP for 15 min at 37~ 
Afterwards, the calls were washed once with cold PBS and stained 
with PE-labded mAbs against different cell surface molecules for 
30 rain on ice. After washing twice with PBS, the cells were ana- 
lyzed by flow cytometry. The monocytes were identifed by their 
light-scatter distribution.  The alteration in mAb binding due to 
mAb KIM127 preincubation was calculated by the comparison of 
the mean fluorescence  intensity (MFI) of mAb KIM127 to control 
mAb incubated  monocytes  and expressed  in percent change of  MFI. 
Results 
uPA-R is Associated with Protein Kinases.  To evaluate as- 
sociation of uPA-R with protein kinaseg we solubilized human 
monocytes using the mild detergent Brij-58  and subjected 
the lysate to immunoprecipitation followed by in vitro ki- 
nase assay and SDS-PAGE analysis. Independent of the iso- 
type of the anti-uPA-R mAbs used for precipitation,  and 
the fine specificities of  these antibodies, i.e., competing (mAbs 
VIM5,  no.  3936)  or non-competing (mAbs E4;  F10  [not 
shown]) with binding of the natural ligand u-PA, we ob- 
tained a similar pattern of labeled proteins with molecular 
masses  of ",~55-60,  85,  100, and 120 kD.  Interestingly, a 
similar pattern of in vitro phosphorylated zones, with an ad- 
ditional strong 40-kD component, was obtained with mAb 
IV.3 directed to the Fc3~-receptor type II (Fc~RII, CD32) 
(Fig.  1 A).  This indicates that in monocytes also,  F~RII 
is associated with protein kinases as was described with gran- 
ulocytes (31), and monocytic ceils (32) previously. Therefore, 
to rule out the possibility that coprecipitation of the protein 
kinase activity by mAbs to uPA-R was due to their interac- 
tion with Fc3~Rs, we performed in vitro kinase assay on the 
uPA-R affinity  isolated from monocyte detergent lysate using 
its natural ligand, uPA. As shown in Fig. 1 B, the same pat- 
tern of in vitro phosphorylated proteins was obtained. Thus, 
coisolation ofphosphoproteins pp55-60, pp85, ppl00, pp120, 
and protein kinase activity with uPA-R is independent of 
Fc3,R,  indicating that  uPA-R  is  a  component of a  mul- 
Figure 1.  Coisolation  of protein kinase  activity  with uPA-R. Mono- 
cytes  were  lysed  and in vitro  kinase  assay  on isolated  uPA-R  was performed. 
Presence of  in vitro-labeled  proteins  was detected  by SDS-PAGE  and auto- 
radiography.  (A) uPA-R  was immunoprecipitated  with mAbs VIMS, no. 
3936, and E4. As isotype  control, mAbs  B2M-01, B2M-02, and 132 were 
used. (B) uPA-R  was affinity  isohted  on its ligand  uPA, coupled  to Sepharose 
4B. BSA-coupled  Sepharose  4B was used as a control matrix. Molecular 
mass standards are indicated in kD. 
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is therefore designated in the text as "uPA-R complex". It 
should be noted, that virtually identical results were obtained 
when a more stringent detergent, NP-40, was used for solubili- 
zation (data  not shown). 
Determination of  the Size of  the uPA-R Complex.  The exis- 
tence of large detergent resistant complexes containing GPI- 
anchored proteins, (glyco)lipids, and protein kinases has been 
recently described by us (27, 33) and others (34-37). To test 
whether uPA-R complex has similar properties, we deter- 
mined its size by fractionation of monocyte  lysate employing 
gel filtration on a Sepharose 4B column (27). In the first set 
of experiments, we analyzed resulting fractions for uPA-R/pro- 
tein kinase association.  When we isolated uPA-R using its 
natural ligand, uPA, we detected kinase activity only in frac- 
tions 4 and 5, and the pattern of phosphoproteins was iden- 
tical to that obtained from unfractionated lysate (Fig. 2). Be- 
cause of the calibration of the column with erythrocytes, IgM 
and IgG, the fractions 4 and 5 correspond to the column void 
volume. Inasmuch as the exclusion limit of Sepharose 4B is 
in the range of tens of millions of daltons, this indicates  a 
relatively large size of the uPA-R complex. To follow the 
distribution of the total uPA-tL, and to analyze whether com- 
plexes of different composition or free forms exist,  the par- 
ticular fractions were subjected to SDS-PAGE and immuno- 
blotting using anti-uPA-P, mAb H2. All detectable uPA-R 
was found in void volume fractions,  demonstrating that at 
least a majority of uPA-R is present in the complexes of large 
size (Fig. 3 A). In contrast, several other abundant monocyte 
surface proteins, such as CD43 (Fig. 3 B), CD18, CD32, and 
CD45RA  (not  shown)  were  detected in  fractions  corre- 
sponding both to the large complexes,  and to single mole- 
cules (or simple complexes). 
Identification ofuPA-R-associated PTKs.  We (27, 33, 38) 
and others (25, 35, 36, 39-41) have previously described as- 
sociation of several GPI-anchored proteins with members of 
Figure 2.  Determination of the size of uPA-IL  complex. Monocyte ly- 
sate was size fractionated using a Sepharose  4B column, uPA-tL  was affinity- 
isolated on its ligand, uPA, from the individual fractions, and analyzed 
by in vitro kinase assay. Presence of kinase activity was detected.by SDS- 
PAGE and autoradiography. The fraction numbers are indicated at the top. 
The elution volumes of erythrocytes (ERY), IgM, and IgG are shown at 
the bottom. Molecular mass standards are indicated in kD. 
Figure 3.  Distribution  of 
monocyte antigens  in size-fraction- 
ated monocyte  lysate. Monocyte  1y- 
sate was size-fractionated  using a 
Sepharose 4B column and the re- 
suiting fractions (indicated on the 
top) were analyzed by immuno- 
blotting with the following Abs: 
(A) H2 to uPA-R; (B) MEM-59 
to CD43; (C) anti-Lyn; (/9) anti- 
Fgr; (E) anti-Hck; (F) anti-Fyn. 
A similar  distribution as for CD43 
was found for CD18, CD32 and 
CD45ILA. 
the Src-family of PTKs.  Among them, p60  ~y", p53/56 lyn, 
p58/64  hck, and p59f8  r are expressed by monocytes, and au- 
tophosphorylated or phosphorylated in vitro (25, 42). Thus, 
the presence of the 55-60 kD in vitro phosphorylated pro- 
teins in the uPA-R complex (Fig. 1) suggested identity with 
some of those. When we analyzed size-fractionated  mono- 
cyte lysate (see above) by immunoblotting,  we found a different 
distribution of the individual PTKs in the particular frac- 
tions (Fig.  3 C-F).  However,  all of them were detected in 
void volume fractions, indicating presence of subpopulations 
of these kinases in complexes of the similar size to that found 
for the uPA-R complex. Indeed, the PTKs p60  fyn, p53/56  lyn, 
p58/64  ha, and p59f~ were dearly demonstrated by reprecipi- 
tation of in vitro phosphorylated material from the uPA-R 
complex by means of specific antibodies (Fig. 4 A), as well 
as by immunoblotting analysis of isolated uPA-R complex 
(Fig.  4 B). 
Stimulation Via uPA-R Complex Involves Tyrosine  Phsosphory- 
lation.  Our finding that several members of the Src-family 
of PTKs are associated with uPA-R prompted us to examine 
possible tyrosine phosphorylation  upon stimulation of mono- 
cytes with uPA. Indeed anti-phosphotyrosine immunoblot- 
ting analysis of monocyte lysates revealed that both active 
and DFP enzymatically inactivated uPA (DFP-uPA) induced 
tyrosine phosphorylation on several proteins in the range of 
26-30 and 38-40 kD as compared to the medium control 
(Fig. 5). We did not detect phosphoproteins of similar size 
by the anti-phosphotyrosine  immunoblotting analysis of the 
uPA-R complex, which was isolated  from these monocyte 
lysates in parallel by using mAb E4 directed against a non- 
ligand-binding domain of the uPA-R (data not shown). These 
phosphoproteins in the range of 26-30 and 38-40 kD were 
also not seen in the in vitro kinase assay on isolated uPA-R 
(Figs.  1 and 2). Therefore, these findings suggest that the 
molecules tyrosine phosphorylated after the engagement of 
1384  Urokinase  Receptor  Complex  on Monocytes Figure  4.  Identification  of Irl'Ks  coisolated  with uPA-R. (A) uPA-R 
was affinity  isolated  on uPA-Sepharose  from  void  volume  fractions  of  mono- 
cyte  lysate,  and subjected  to in vitro  kinase  assay,  trrKs were  reprecipitated 
employing  the indicated  Abs, and the resulting  precipitates  were  analyzed 
by SDS-PAGE and autoradiography.  (B) uPA-R was affinity-isolated  on 
uPA-Sepharose from void  volume  fractions  of monocyte  lysate,  and ana- 
lyzed  by immunoblotting  with the indicated  Abs. Normal rabbit serum 
(NRS) was used  as control.  Molecular  weight  standards  are indicated  in kD. 
uPA-R are downstream components of  the signaling pathways 
rather than immediate associated substrates of the PTKs present 
in the uPA-R complex. 
Identification of Further Components of the uPA-R Complex. 
The PI3-K is an important signaling molecule, whose 85-kD 
subunit associates with several cell surface receptors,  and can 
be tyrosine phosphorylated (43). However, neither by repre- 
cipitation nor immunoblotting were we able to demonstrate 
the identity of this enzyme subunit to the in vitro phos- 
phorylated 85-kD  protein present in the uPA-R complex 
(Fig. 4, A  and B). 
Analysis of the size-fractionated cell lysate by immunoblot- 
ting indicated the presence of monocyte GPI-linked proteins 
CD14, CD58, and CD59 in the Sepharose 4B void volume 
fractions corresponding  to  the large complexes  (data  not 
shown). Due to our previous experience with the simultaneous 
presence of considerable amounts of several GPI-anchored pro- 
teins in large complexes  (27,  33),  we analyzed the uPA-R 
complex by immunoblotting using CD14, CD58, and CD59 
mAbs. The result was negative (Fig.  6 A), indicating that 
none of these molecules, or only a small amount below the 
detection level of our assay, were present. 
Recent reports  have  shown a relationship between  the 
Figure  5.  Induction of tyro- 
sine phosphorylation  upon incu- 
bation of monocytes  with uPA. 
Monocytes  were incubated  with 
uPA, DFP-inactivated uPA, or 
with medium  alone  for 5 and 15 
min.  Tyrosine phosphorylated 
proteins were  visualized  by immu- 
noblotting  using  mAb 4G10. Mo- 
lecular  weight  standards  are indi- 
cated in kD. 
Figure 6.  Identification  of proteins coisolated  with uPA-R, uPA-R  was 
affinity  isolated  on uPA-Sepharose  from  void volume  fractions  of mono- 
cyte  lysate,  and analyzed  by SDS-PAGE  and immunoblotting  with the fol- 
lowing  mAbs: (A) H2 to uPA-R, MEM-18  to CD14, MEM-43  to CD59, 
TS2/9 to CD58; analysis  was performed  using a 12.5% SDS-polyacryl- 
amide gel. (B) MEM-59 to CD43, MEM-56 to CD45RA, MEM-48 to 
CD18, MEM-95 to CDlla, PEN-2 to CDllb, Ki-M1 to CDllc; analysis 
was performed  using  a 7.5% SDS-polyacrylamide  gel. Molecular  weight 
standards are indicated in kD. 
detergent-resistant  membrane  domains  enriched  in  GPI- 
anchored proteins and the plasma membrane invaginations 
termed caveolae in epithelial cells. Since the caveola coat pro- 
tein caveolin is a v-Src substrate and seems to have a trans- 
membrane topology, caveolin has been suggested to be in- 
volved in transmembrane signaling via GPI-anchored proteins 
in these cells (44). Therefore, we wanted to evaluate the role 
of caveolin in signaling via uPA-K in monocytes. However 
by using two anti-caveolin Abs in immunoblotting, we were 
unable to detect caveolin in detergent lysates of monocytes, 
while it was readily found in human fibroblast lysates under 
the same conditions (data not shown). 
Subpopulations of several transmembrane monocyte an- 
tigens, including CD43, CD18, CD32, and CD45RA were 
found in Sepharose 4B void volume fractions (Fig. 3 B, and 
data not  shown).  From them,  only CD18,  the  common 
subunit of ~2-integrins, was identifed in uPA-R complex 
by immunoblotting (Fig.  6 B). 
uPA-R Complex Contains the B2-integrins LFA-1 and CR3. 
Initially we tried to determine which of the ~2-integrins, 
LFA-1 (CDlla/CD18), CK3 (CDllb/CD18), CR4 (CD11c/ 
CD18), are involved in the uPA-R complex by direct iden- 
tification of the oL-chains  (CDll) using immunoblotting. For 
this, 12 mAbs against CDlla, 10 mAbs against CDllb, and 
6 mAbs against CDllc were screened for immunoblotting 
reactivity with monocyte lysate, mAbs MEM-95 to CDlla, 
PEN-2 to CDllb, and Ki-M1 to CDllc were selected as the 
best reacting. Even with these mAbs we were unable to iden- 
tify which CDll molecule is present in the uPA-R complex 
(Fig. 6 B). Therefore, a reverse approach was taken. We im- 
mobilized mAbs to CD18, CDlla, CDllb, and CDllc on 
Eupergit CIZ microparticles, and used these immunosorbents 
to isolate the subpopulations of/$2-integrins from the Seph- 
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B2-integrins.  B2-integrins  were precipitated 
from Sepharose 4B void volume fractions of 
monocyte lysate  using the following mAbs im- 
mobilized on Eupergit C1Z particles: MEM-48 
to CD18, MEM-83 to CDlla, MEM-170 to 
CDllb, BU-15  to  CDllc, and MEM-57  to 
CD3 (c0ntro/). Resulting  predpitates were ana- 
lyzed by immunoblotting  with mAb MEM-48 
to  CD18,  H2  to  uPA-R,  and B2M-02  to 
Bz-microglobulin (control).  Positions of uPA-R 
and CD18 are indicated by arrows. Molecular 
weight  standards are given in kD. 
arose 4B void volume fractions of monocyte lysate, where 
the uPA-R complex was present. The resulting material was 
analyzed by immunoblotting  with anti-uPA-R mAb H2. As 
shown in Fig.  7, we were able to demonstrate the specific 
50-65-kD zone corresponding to uPA-R in the immuno- 
precipitates  of CD18,  CDlla,  CD11b,  but not CD11c,  al- 
though also here, the considerable amount of detected CD18 
indicated the efficiency of precipitation. 
raAbs to ~2-integrins Induce Cocapping and Modulation of 
uPA-R.  Our biochemical data indicated that only subpopu- 
lations of the B2-integrins and the Src-l~Ks are present in 
the uPA-R complex (Fig. 3). Therefore, it could be expected 
to be technically  difficult to demonstrate the uPA-R com- 
plex in the intact monocyte. Neverthdess, two of the per- 
formed approaches provided further evidence for its existence 
on the surface of monocytes. 
First, we were able to induce CR3 capping on "~70% of 
the monocytes by cross-linking of CDllb mAb MEM-170 
with FITC-conjugated F(ab')2 firagments of sheep anti-mouse 
Ig and shifting the cells for 5 rain to 37~  (Fig. 8 A). When 
we stained these cells with biotinylated uPA and TILITC- 
conjugated streptavidin, a dear codistribution of uPA-R and 
CR3 was observed on 40-50%  of the capped cells (Fig.  8 
B). This result is in good agreement with the recently reported 
cocapping of uPA-R and CR3 on granulocytes (45). The effect 
was less pronounced with CD18 capped cells and hardly seen 
with CDlla capped cells. As a control, no codistribution of 
uPA-R was observed after capping of the monocyte surface 
protein CD31 (Fig. 8, C and D). Using a similar approach, 
we were unable to demonstrate unequivocally cocapping of 
the Src-family PTKs p60%, p53/56  lye, p58/64  hal, and p56  fsr 
with  uPA-R  or  CR3.  Although there was  a  somewhat 
stronger accumulation of the FFKs in the uPA-R or CR3 
caps, most of them remained homogeneously  distributed. This 
is most likely because only minor fractions of the PTKs are 
engaged within the complex. 
The second approach was undertaken after we found down- 
regulation of monocyte  B2-integrins by incubation with CD18 
mAb KIM127.  Then we estimated the influence on uPA-R 
by staining the/~2-integrin modulated cells with PE-conju- 
gated mAb VIM5 and FACS  |  (Becton Dickinson and Co., 
Mountain View, CA) analysis. The results were similar for 
each of the three experiments, one of which is shown in Fig. 
9. The MFI of the cells stained by PE-labeled anti-uPA-R 
mAb VIM5 modestly but reproducibly decreased after the 
mAb KIM127 treatment by 14 _+ 4% (mean +  SD) in com- 
parison to control mAb incubated cells. Binding of CDllb 
mAb VIM12 was diminished  by 12 +  3% and that of CDlla 
Figure 8.  Colocalization  of uPA-R and 
CR3. Representative fluorescence photomi- 
crographs  of  cocapping  experiments  are 
shown. (A) CR3 was first capped using mAb 
MEM-170 to the a-chain CDllb and FITC- 
conjugated F(ab')2  fragments of a sheep anti- 
murine Ig antiserum.  (B)  The monocytes 
were then labeled with biotinylated uPA and 
TRITC-conjugated streptavidin. As a con- 
trol, (C') CD31 mAb 7E4 capped cells (/9) 
that were probed with uPA. 
1386  Urokinase  Receptor  Complex  on Monocytes Figure 9.  Modulation ofuPA-R by/~2-integrin ~-r  mAb KIM127. 
Cells were incubated with CD18 mAb KIM127 at 37~  for 15 rain, stained 
with PE-hbeled mAbs (VIM5 to uPA-R, VIM12 to CD11b, 5E6 to CDlla, 
71/4 to CD31), and analyzed by flow cytometry. The alterations in binding 
of the direct-labeled mAbs due to the KIM127 preincubation  are ocpressed 
as percent change in MFI in comparison  to cells incubated  with control 
mAb VIAP. 
mAb 5E6 by 7  +_  3%.  On the other hand, no change in 
the staining of CD31 mAb 7E4 was detected. We interpret 
this effect as comodulation of uPA-R with 32-integrins. An 
alternative explanation based on possible steric hindrance of 
the mAbs is unlikely as no such effects were found when 
the experiment was done with prefixed  monocytes. Taken 
together, these results support the coisolation experiments 
considering that a part of the 32-integrins is physically associ- 
ated with uPA-R on the surface of intact human monocytes. 
Discussion 
In the present study, we found uPA-R as a component 
of a relatively large receptor complex in human monocytes 
including 32-integrins, and four PTKs of the Src-family. The 
proximity of molecules involved in adhesion, extravasation, 
chemotaxis, pericellnlar  proteolysis,  as well as intracellular 
signal transduction may obviously provide opportunities for 
their mutual interactions. Therefore, it is tempting to specu- 
late that this uPA-R complex is a "switchboard" involved 
in regulation of monocyte migration. 
Interaction of ligand binding receptor dements and pro- 
tein tyrosine kinases, resulting in modulation of kinase ac- 
tivity and tyrosine phosphorylation represent the first steps 
in a cascade of events accompanying  leukocyte activation. As 
we demonstrate, this seems to be true also for signaling via 
uPA-R. By isolation of the monocyte uPA-R using its nat- 
ural ligand, uPA, we identified its association with the Src- 
family PTKs p60%, p53/56  ]y~, p58/64  hck, and p59f~ (Fig. 
4). Involvement of these kinases in uPA-R signaling is sup- 
ported by induction of tyrosine phosphorylation upon stim- 
ulation of monocytes with uPA, independently of its enzy- 
matic activity (Fig.  5).  This finding is in agreement with 
uPA-stimulated tyrosine phosphorylation in U937 ceils (16). 
Indeed, we also coisolated phosphotransferase activity with 
uPA-R from lysates of these cells (not shown). 
How can uPA-R be associated with FI"Ks, and how can 
uPA-R be involved in uPA-induced cellular adhesion (12, 13) 
and chemotactic movement (14, 15)? These are particularly 
important questions, since uPA-R belongs to the family of 
GPI-anchored membrane proteins. Attached to the outer leaflet 
of the membrane via its lipid moiety, and thus devoid of trans- 
membrane and  cytoplasmic domains,  uPA-R  presumably 
cannot directly interact with PTKs which are restricted to 
the inner leaflet of the membrane through their covalently 
linked fatty acid residues (46). However, as our data and sev- 
eral previous reports show (25,  38-40),  tight physical and 
functional interrelations between GPI-anchored proteins and 
PTKs do exist. Therefore, it was speculated that an adaptor, 
possible candidates for which could be specific (glyco)lipids 
or transmembrane proteins, must be present to mediate the 
contact (37, 47). Such a linker molecule could be a mere con- 
nector or bear various functional properties. Upon ligation, 
GPI proteins could interact and activate  this structure and 
subsequently also downstream signaling cascades. Caveolin, 
a 22-kD protein with putative type II transmembrane orien- 
tation has been hypothesized to play such a role in epithelial 
caveolae and endothelial "caveolin-rich  domains;' in which 
GPI-anchored proteins are concentrated (44). Since we were 
not able to detect any caveolin in monocytes, this indicates 
that caveolin may not be an essential component of at least 
some types of membrane domains enriched in GPI-anchored 
proteins. In this respect, our demonstration that uPA-R and 
PTKs are joint components of a single receptor complex con- 
raining the leukocyte-integrins LFA-1 and CR.3 is of partic- 
ular interest. Because of their transmembrane topology, pro- 
posed existence of allosteric modifications (48) and interaction 
with the cytoskeletnn (49), LFA-1 and CR3 can principally 
provide uPA-R access to intracellular signaling cascades. 
B2-integrins are crucial molecules for leukocyte adhesion 
and migration. However, leukocyte integrins are not merely 
passive adhesion molecules (50, 51). It was shown that they 
are able to transduce signals in neutrophils (52, 53) and lym- 
phocytes (54), which is accompanied  by tyrosine phosphory- 
lation of intracellnlar substrates  (55).  Cytoplasmic parts of 
integrins seem to be important for their signaling (48). In- 
terestingly, an uncharacterized protein kinase activity associated 
with LFA-1 has been reported earlier (56).  Indications that 
32-integrins functionally cooperate with GPI-anchored pro- 
teins were provided by several reports. Engagement of CD14 
activates the adhesive capacity of CR3 on neutrophils (57), 
and that of LFA-1 on monocytes (58).  In agreement with 
our data, antibody induced cocapping of uPA-R (45) and 
CD16 (Fc3,RIII) (59) with CR3 have been observed on neu- 
trophils. This seems to be dependent on lectin-like interac- 
tions between the molecules involved. Importantly, disrup- 
tion of this interaction leads to decreased CD16 signaling (52). 
However,  so far it has not been known what is the struc- 
tural bails of this functional relationship between GPI-anchored 
proteins and 32-integrins, i.e., whether these molecules are 
physically associated within some type of a membrane com- 
plex. By coisolation from lysates of freshly prepared human 
peripheral blood monocytes, we show here that the GPI- 
anchored protein uPA-R is associated with subpopulations 
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a relatively large size. This finding is supported by the ob- 
served mAb-induced colocalization of uPA-K and integrins 
on 40-50% of CR3 capped ceils (Fig. 8). Although we cannot 
completely rule out the possibility that ligation of integrins 
by mAbs enhances these associations,  these observations sug- 
gest that uPA-K complex is a constitutive receptor domain 
on monocytes rather than on a minor "activated" subpopula- 
tion of these cells. The occurrence in large complexes with 
limited solubility is not unique for uPA-R. Several other GPI- 
anchored proteins have been found to be components of very 
large, detergent-resistant  complexes (27, 33, 36) corresponding 
presumably to membrane microdomains of specific lipid com- 
position (34, 35, 37). Such accumulation of receptors in large 
complexes could be important for strengthening of effector 
functions  (pericellular proteolysis,  adhesion) by crowding 
effector molecules as well as for the channeling of signals. 
The compositions of these relatively large "GPI-domains" 
seem to differ in various cells but also in a given cell type. 
There is basically  a single type of GPI-domain containing 
several GPI-anchored proteins joined together in T ceUs (27, 
33).  Here we show,  that the uPA-R complex is a type of 
such large membrane complexes in monocytes, that dearly 
contains transmembrane proteins, i.e., the 32-integrins. The 
absence of at least substantial amounts of the abundant GPI- 
anchored proteins (CD14, CD58, CD59) in these uPA-R com- 
plexes (Fig.  6 A), but their presence in Sepharose 4B void 
volume fractions (data not shown) suggests that monocyte 
membranes contain more than one type of large complexes 
(microdomains) involving different major GPI-anchored pro- 
teins.  In monocytes we did not find caveolin,  the coat pro- 
tein of GPI protein-enriched domains in epithelial cells (44), 
which on the other hand lack B2-integrins. This further points 
to the heterogeneity of these membrane receptor domains. 
An unclear question is whether the composition of these com- 
plexes is changed upon cell activation. Inasmuch as uPA-R 
is a possible target in the treatment of tumor metastasis  as 
well as inflammatory disorders, careful analysis of the com- 
position and stoichiometry of these uPA-K complexes in in- 
dividual cells under resting and activation state might pro- 
vide a basis  to develop specific therapeutic strategies. 
We conclude, that the large, PTK-containing complex de- 
scribed here is most likely involved in signal transduction 
through two different types of receptors, uPA-R and B2- 
integrins. A coordinated action of extracellular proteolysis, 
adhesion, and cell activation at the right time and place is 
obviously required for cell migration. Therefore, it can be 
speculated that close proximity of these two types of receptors, 
and sharing of the common intracellular signaling molecules 
may be important for these processes. 
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